Department of Psychiatry, New York-Presbyterian/Weill Cornell Medicine, New York, NY, USA.
Department of Psychiatry, Weill Cornell Medicine, New York, NY, USA.
Ann Palliat Med. 2024 Mar;13(2):433-439. doi: 10.21037/apm-23-586. Epub 2024 Mar 19.
Palliative psychiatry is an emerging field that suggests a role for palliative interventions in the management of severe and persistent mental illness (SPMI). Current literature describes using a palliative approach for patients with severe anorexia nervosa. To our knowledge, this is the first case report describing end-of-life care in a patient with treatment-refractory catatonic schizophrenia.
We describe the case of a 49-year-old man with schizophrenia and severe chronic agitated/malignant catatonia who was hospitalized for ten months. Multiple treatment trials including medication such as neuroleptics and benzodiazepines, electroconvulsive therapy, and empiric interventions such as intravenous immunoglobulins were either not tolerated or did not result in clinically significant improvement. The patient continued to intermittently require intubation and sedation to control intractable behavioral and psychiatric disturbances. Ultimately, with collaboration of psychiatry, neurology, ethics, intensive care, and palliative care teams, the patient's parents decided to forgo further diagnostic testing and life-sustaining treatments. The patient died weeks later of aspiration pneumonia with good symptom control.
This case permits discussion of palliative interventions in patients with SPMI such as treatment-refractory psychotic disorders who likely cannot achieve a quality of life that is acceptable to them. Here, it can be justified to prioritize relief of suffering and prevention of further burdensome interventions over treatment of the SPMI symptoms such as catatonia and even over keeping the patient alive.
姑息精神病学是一个新兴领域,它提出姑息干预措施在严重和持续精神疾病(SPMI)的治疗中的作用。目前的文献描述了在严重神经性厌食症患者中使用姑息方法。据我们所知,这是首例描述难治性紧张型精神分裂症患者临终关怀的病例报告。
我们描述了一例 49 岁男性,患有精神分裂症和严重慢性激越/恶性紧张症,他住院了十个月。包括神经阻滞剂和苯二氮䓬类药物、电惊厥疗法以及静脉注射免疫球蛋白等经验性干预在内的多种治疗试验,要么无法耐受,要么没有导致临床显著改善。患者仍间歇性需要插管和镇静来控制难治性行为和精神障碍。最终,在精神病学、神经病学、伦理学、重症监护和姑息治疗团队的协作下,患者的父母决定放弃进一步的诊断测试和维持生命的治疗。数周后,患者死于吸入性肺炎,症状得到良好控制。
该病例允许讨论姑息干预措施在 SPMI 患者中的应用,例如治疗难治性精神病障碍患者,他们可能无法获得他们可接受的生活质量。在这里,可以合理地将缓解痛苦和预防进一步的负担性干预措施置于治疗 SPMI 症状(如紧张症)甚至维持患者生命之上。